Pseudomembranous colitis prevention: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
Line 14: | Line 14: | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] | ||
[[Category:Conditions diagnosed by stool test]] | [[Category:Conditions diagnosed by stool test]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Patient information]] | [[Category:Patient information]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WS}} | {{WS}} |
Latest revision as of 18:50, 18 September 2017
Pseudomembranous colitis Microchapters |
Differentiating Pseudomembranous Colitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pseudomembranous colitis prevention On the Web |
American Roentgen Ray Society Images of Pseudomembranous colitis prevention |
Risk calculators and risk factors for Pseudomembranous colitis prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
A randomized controlled trial using a probiotic drink containing Lactobacillus casei, L bulgaricus, and Streptococcus thermophilus was reported to have some efficacy. This study was sponsored by the company that produces the drink studied [1]. Although intriguing, several other studies have been unable to demonstrate any benefit of oral supplements of similar bacteria at preventing CDAD.
References
- ↑ Hickson M, D'Souza AL, Muthu N; et al. (2007). "Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial". BMJ. 335 (7610): 80. doi:10.1136/bmj.39231.599815.55. PMID 17604300.